Navigation Links
Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
Date:6/30/2008

F(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; and deCODE Glaucoma(TM) for a major type of glaucoma. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com; on our diagnostics website at http://www.decodediagnostics.com; and, for our pioneering personal genome analysis service, at http://www.decodeme.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk fact
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
2. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
3. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
4. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
5. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
6. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
7. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
8. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
9. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
10. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
11. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 A new ... manage the clinical review of specialty pharmaceuticals has ... of drugs reviewed while reducing costs. ,, AIM, ... company with health plan clients representing over 35 ... Inc. (NYSE: WLP ), adapted the ...
(Date:12/16/2009)... REYKJAVIK, Iceland, December 16 Scientists at,deCODE ... journal Nature the,discovery of a version of a ... genome (SNP) with a major impact on susceptibility ... T2D variant is not only large, but unusual:,if ... variant increases risk of,T2D by more than 30% ...
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3A new bent on fusion 9637 1A new bent on fusion 9637 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3ESCO Announces Major Contract Award for Its Thermoforming Business 54966 1ESCO Announces Major Contract Award for Its Thermoforming Business 54966 2
... by the European Commission, ATRIPLA Would Represent the, First and Only Once-Daily ... ... PRINCETON, N.J., FOSTER CITY, Calif. and WHITEHOUSE STATION, N.J., Oct.,18 Bristol-Myers ... and Merck & Co., Inc. (NYSE: MRK ),announced today that the ...
... Society for Reproductive Medicine meeting could significantly improve ability to identify embryos ... patients, AFA supports efforts to bring advanced screening technology to patients as,quickly as ... ... procedures, NEW YORK, Oct. 18 According to results ...
Other Medicine Technology:European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 2American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 3
(Date:12/17/2009)... selected Jay and Maureen Neitz, the husband-and-wife team whose ... therapy to treat vision disorders, as the inaugural recipients ... , The award is funded by a $1 million ... graduates Jay Pepose ,75 and Susan K. Feigenbaum ,74, ... in vision science. , The Neitzes, both of whom ...
(Date:12/17/2009)... particle might someday ease accompanying lung infections , , THURSDAY, ... pneumonia when infected with the swine flu virus, and ... , A key to the severity of the illness ... which helps the immune system fight off germs and ... swine-flu patients at 10 Spanish hospitals last summer found ...
(Date:12/17/2009)... Scientific Studies Important ,for the R&D Informatics Industry, , ... ... -- Cambridge Healthtech Institute is pleased to announce the participation ... Adopting R&D Informatics Systems conference to be held on February ... Francisco, CA. This meeting has been integrated in the Informatics ...
(Date:12/17/2009)... Dec. 17 It,s customary for the holidays ... any busy time of year, workouts often get short-changed ... to celebrity fitness trainer Valerie Waters, it is not ... the window. That,s why California Raisins and Waters have ... wise choices during the holiday season and get a ...
(Date:12/17/2009)... The recently opened Laser Spine ... the community in full force this holiday season, as ... 13th, benefiting the Arthritis Foundation, a non-profit organization dedicated ... event boasted 1,500 attendees, spotlighting LSI,s passion for their ... renowned, national fundraiser and a festive way to get ...
Breaking Medicine News(10 mins):Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2
... today,s scientific program of the 2008 Joint Meeting of ... of Ophthalmology (SOE) include a study that correlates optic ... and potentially elevated risk for stroke, and a survey ... to the world,s seven major religions, may affect patient ...
... older age and high weight gain, are known ... pressure disorders. Now a new report suggests that ... increase the risk of pre-eclampsia and pregnancy-induced hypertension ... American Society of Nephrology,s 41st Annual Meeting and ...
... Cataract Surgery Patients can Better Understand Their Condition at CataractSurgery.com ... ... Cataract surgery patients and their caregivers now have a new online ... . Cataracts affect nearly 20 million Americans age 60 ...
... Nov. 7 Ninety years ago today,the guns fell silent ... all wars" -,was over. Almost five million Americans served during ... 107-year-old Army veteran,Frank Buckles, observes this Veterans Day at his ... Day, for all Americans to reflect on the,service and sacrifice ...
... stress fractures, experts say, , , FRIDAY, Nov. 9 (HealthDay News) ... strengthen bones in older women. These vital nutrients may also ... , To illustrate that point, many bone health experts refer ... Navy recruits that found that women who didn,t take additional ...
... After playing a,pivotal role in helping turn around the ... Mogel, President and Chief Executive,Officer of Integrated Healthcare Holdings, ... of IHHI. He will continue to serve,as Chief Executive ... December 31, 2008., "In his four years with ...
Other Medicine News:Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 2Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 3Health News:AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights 4Health News:Rural women are at higher risk of blood pressure disorders during pregnancy 2Health News:Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery 2Health News:A Veterans Day Message From VA Secretary Dr. James B. Peake 2Health News:A Veterans Day Message From VA Secretary Dr. James B. Peake 3Health News:A Veterans Day Message From VA Secretary Dr. James B. Peake 4Health News:Active Young Women Need Calcium, Vitamin D 2Health News:Active Young Women Need Calcium, Vitamin D 3Health News:Chief Executive Officer Leaving Integrated Healthcare Holdings, Inc. 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: